55.69
BATS BZX Real-Time Price
As of 1:22pm ET
 -1.17 / -2.06%
Today’s Change
45.50
Today|||52-Week Range
70.76
-14.90%
Year-to-Date
Stock Market News for March 06, 2015 - Market News
10:55am / Zacks.com
Did AbbVie Just Grossly Overpay for Pharmacyclics Inc.?
Mar 05 / MotleyFool.com
Jim Cramer on the Market: Here's the Return of Cult Stocks
9:33am / TheStreet.com
Credit Suisse: 8 Biotech and Health Care Stocks Add to Your Portfolio Right Now
Mar 05 / TheStreet.com
AbbVie (ABBV) in Focus: Stock Falls by 5.7% - Tale of the Tape
9:29am / Zacks.com
Abbvie/Pharmacyclics: pay to play
Mar 05 / FT.com
Benzinga's M&A Chatter for Thursday March 5, 2015
Mar 05 / Benzinga
Stock Futures Are Pointing Higher as ECB Lifts Growth Forecast
Mar 05 / TheStreet.com
Jim Cramer's 'Mad Money' Recap: Why Aren't Well-Run Companies Getting Respect?
Mar 05 / TheStreet.com
US Stock Futures Up Ahead Of Jobless Claims, Factory Orders Data
Mar 05 / Benzinga
AbbVie (ABBV) Stock Declines In Trading Today Following $21B Pharmacyclics Purchase
Mar 05 / TheStreet.com
AbbVie (ABBV) Is Today's Pre-Market Laggard Stock
Mar 05 / TheStreet.com
Stocks Notch Small Gains Ahead of February Jobs Report
Mar 05 / TheStreet.com
Why Pharmacyclics Inc. Stock Burst Higher
Mar 05 / MotleyFool.com
The Under-the-Radar Reason Why Puma Biotechnology Inc. Rocketed 17% Higher
Mar 05 / MotleyFool.com
March 5 Premarket Briefing: 10 Things You Should Know
Mar 05 / TheStreet.com
AbbVie wins three-way fight over Pharmacyclics
Mar 05 / FT.com
AbbVie Spending Historic Amount of Cash to Buy Half of a Cancer Drug
Mar 05 / TheStreet.com
AbbVie joins the pharma chain reaction
Mar 05 / FT.com
Q&A - why Abbvie had to strike $21bn Pharmacyclics deal
Mar 05 / FT.com
Vertex climbs on drug approval hopes
Mar 05 / FT.com
China Cuts Growth Target
Mar 05 / TheStreet.com
Centerview builds record on pharma deals
Mar 05 / FT.com
Stocks: 5 things to know before the open
Mar 05 / CNNMoney.com
Stocks' Gains Are Limited in Lead-Up to February Jobs Report
Mar 05 / TheStreet.com
AbbVie (ABBV) Is Today's Unusual Social Activity Stock
Mar 04 / TheStreet.com
Benzinga's Volume Movers
Mar 05 / Benzinga
AbbVie Inc (ABBV) Downgraded From Buy to Hold
Mar 04 / TheStreet.com
Stocks Hitting 52-Week Highs
Mar 05 / Benzinga
Analysts' Actions: AbbVie, Stratasys and More
Mar 04 / TheStreet.com
Morning Market Losers
Mar 05 / Benzinga
Dynavax Technologies: A New 'Best Idea'
Mar 03 / TheStreet.com
Notable Mergers and Acquisitions 3/5: (ABBV)/(PCYC) (MNK) (SMTC)
Mar 05 / Investing Channel
These Stocks Just Raised Their Dividends
Mar 02 / MotleyFool.com
How These Healthcare Megadeals Helped Send the Market Higher
Mar 05 / MotleyFool.com
Billionaire George Soros Just Dumped These 3 Dividend Stocks
Mar 01 / MotleyFool.com
Stock Market News for March 05, 2015 - Market News
Mar 05 / Zacks.com
Biotech Head-to-Head: Gilead vs. Celgene
Feb 26 / MotleyFool.com
Morning Market Gainers
Mar 05 / Benzinga
Express Scripts Earnings Set the Stage for Growth
Feb 24 / MotleyFool.com
AbbVie to Acquire Pharmacyclics: What Wall Street's Saying
Mar 05 / TheStreet.com
There Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks
Feb 22 / MotleyFool.com
On the ECB & China's Growth - Ahead of Wall Street
Mar 05 / Zacks.com
Pssst... Pfizer Just Told Investors That This is the Next Big Thing
Feb 21 / MotleyFool.com
Benzinga's Top #PreMarket Losers
Mar 05 / Benzinga
Will Express Scripts (ESRX) Beat Q4 Earnings Estimates? - Analyst Blog
Feb 20 / Zacks.com
Stocks Grind Higher on ECB's QE While Costco Boosts S&P 500
Mar 05 / TheStreet.com
$20 Billion Market: Whatbs the Best Stock to Buy?
Feb 20 / MotleyFool.com
Benzinga's Top #PreMarket Gainers
Mar 05 / Benzinga
Monday interview: Flemming Ornskov, Shire CEO
Feb 15 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account